Skin Cancer

Merkel Cell Carcinoma

Male, 74 years

Patient Internal ID: 499414644

ICD-10 code

C44.7 Malignant Neoplasms of Skin of Lower Limb and Hip

Diagnosis (Incl. Metastases/Stage) and Year

January 2020
Merkel Cell Carcinoma cTxN2M1, Metastasis to Right Inguinal Lymph Node, Skin of Right Leg.

Previous Treatment

Radiation Therapy, Chemotherapy (Cisplatin/ Etoposide).

Prognosis and Survival Expectation

Merkel Cell Carcinoma (MCC) is a rare but aggressive Skin Cancer. The prognosis remains poor, the development of distant metastases portends a poor prognosis, with a mean life expectancy of 5 months. The 5-year relative survival rate for Advanced Merkel Cell Carcinoma is 24%.

Treatment Provided

CIK (12 doses) o ver a period of 5 months.

Patient Survival/Condition and Year
Date of Review: 28/12/2023

The patient has survived for 11 months since the diagnosis. It can be concluded that the addition of Immunotherapy, alongside Chemotherapy and Radiation Therapy, has extended patient survival by an estimate of around 6 months.

Disclaimer

We encourage you to learn more about your condition and treatment options to make informed decisions about your healthcare. However, please keep in mind that not all information available online or in other sources is accurate or relevant to your specific situation. It’s important to rely on credible, evidence-based sources such as official medical websites, peer-reviewed publications, or information provided by professional healthcare organizations. Always discuss any information you find with your healthcare provider before making decisions, as they can help clarify details, address concerns, and ensure the information is appropriate for your unique needs.

Ok